Barclays’s Nuvalent NUVL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | – | Sell |
-1,268,265
| Closed | -$157M | – | 5627 |
|
|
2026
Q2 | $157M | Buy |
1,268,265
+1,237,421
| +4,012% | +$133M | 0.03% | 379 |
|
|
2026
Q1 | $3.16M | Sell |
30,844
-94,484
| -75% | -$9.6M | ﹤0.01% | 2094 |
|
|
2025
Q4 | $12.6M | Sell |
125,328
-1,552
| -1% | -$153K | ﹤0.01% | 1517 |
|
|
2025
Q3 | $11M | Sell |
126,880
-22,726
| -15% | -$1.8M | ﹤0.01% | 1599 |
|
|
2025
Q2 | $11.4M | Buy |
149,606
+53,569
| +56% | +$3.92M | ﹤0.01% | 1483 |
|
|
2025
Q1 | $6.81M | Sell |
96,037
-2,084
| -2% | -$163K | ﹤0.01% | 1680 |
|
|
2024
Q4 | $7.68M | Buy |
98,121
+30,014
| +44% | +$2.8M | ﹤0.01% | 1784 |
|
|
2024
Q3 | $6.97M | Buy |
68,107
+40,754
| +149% | +$3.38M | ﹤0.01% | 1768 |
|
|
2024
Q2 | $2.07M | Sell |
27,353
-4,097
| -13% | -$291K | ﹤0.01% | 2114 |
|
|
2024
Q1 | $2.36M | Sell |
31,450
-56,655
| -64% | -$4.51M | ﹤0.01% | 2433 |
|
|
2023
Q4 | $6.48M | Buy |
88,105
+36,862
| +72% | +$2.28M | ﹤0.01% | 1877 |
|
|
2023
Q3 | $2.36M | Buy |
51,243
+8,010
| +19% | +$356K | ﹤0.01% | 1787 |
|
|
2023
Q2 | $1.82M | Buy |
43,233
+11,710
| +37% | +$443K | ﹤0.01% | 1948 |
|
|
2023
Q1 | $822K | Buy |
31,523
+2,085
| +7% | +$61.7K | ﹤0.01% | 2884 |
|
|
2022
Q4 | $877K | Buy |
29,438
+28,721
| +4,006% | +$801K | ﹤0.01% | 2911 |
|
|
2022
Q3 | $14K | Sell |
717
-131
| -15% | -$2.19K | ﹤0.01% | 4185 |
|
|
2022
Q2 | $11K | Sell |
848
-2,128
| -72% | -$22.5K | ﹤0.01% | 4601 |
|
|
2022
Q1 | $41K | Buy |
+2,976
| New | +$43.2K | ﹤0.01% | 4194 |
|
Other funds holding NUVL
Barclays's NUVL Position: Q3 2026 in Review
Barclays sold out of Nuvalent (NUVL) in Q3 2026, closing a stake of 1,268,265 shares — an estimated $157M sold.
Barclays first reported a position in NUVL in Q1 2022 and held it in 18 quarters. The position peaked at $157M in Q2 2026. 2 funds tracked by Wall St. Rank hold NUVL as of Q3 2026.
- Barclays reported no remaining Nuvalent position as of Q3 2026 after selling out during the quarter.
- Barclays sold 1,268,265 Nuvalent shares in Q3 2026, an estimated $157M.
- Barclays first reported a position in Nuvalent in Q1 2022 and held it in 18 quarters.
- Barclays's Nuvalent position peaked at $157M in Q2 2026.
- 2 funds tracked by Wall St. Rank held Nuvalent as of Q3 2026.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.